StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) stock

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$11.14−0.16 (-1.42%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

NovoCure price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

NovoCure's price to book ratio was 4.1× on Nov 11, 2026, against 4.2× a year earlier. Over the last 5 years it ranged from 3.3× to 21.5×, with a median of 5.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.1×−0.1
2025Dec 31, 20254.2×−4.7
2024Dec 31, 20248.9×+4.9
2023Dec 29, 20234.0×−13.2
2022Dec 30, 202217.3×−1.6
2021Dec 31, 202118.9×−38.5
2020Dec 31, 202057.3×+13.5
2019Dec 31, 201943.8×+16.7
2018Dec 31, 201827.1×+11.6
2017Dec 29, 201715.5×+11.2
2016Dec 30, 20164.3×+2.0
2015Dec 31, 20152.3×–

More NovoCure figures

See a number that looks wrong?